Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet Rich Plasma in Knee Osteoarthritis
NCT05080075Phase 1Completed
- Sponsor
- University of Toledo Health Science Campus
- Start
- Dec 2021
- Primary completion
- Nov 2023
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous platelet-rich plasma in osteoarthritis (OA), sponsored by University of Toledo Health Science Campus. Primary endpoints: Visual Analog Scale Pain Score at 1 year, Western Ontario and McMaster Universities Osteoarthritis Index at 1 year and 1 more. Started Dec 2021; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05080075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05080075.